Carr Financial Group Corp Novartis Ag Transaction History
Carr Financial Group Corp
- $341 Billion
- Q3 2024
A detailed history of Carr Financial Group Corp transactions in Novartis Ag stock. As of the latest transaction made, Carr Financial Group Corp holds 5,280 shares of NVS stock, worth $550,598. This represents 0.18% of its overall portfolio holdings.
Number of Shares
5,280
Previous 5,280
-0.0%
Holding current value
$550,598
Previous $562 Million
8.04%
% of portfolio
0.18%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,435Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$844 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$728 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$602 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $224B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...